Articles related to Endocrinology, Diabetes, Metabolism

Is Anti-Suicidality Next on the GLP-1 Dropdown Menu?

“These drugs are not weight loss drugs. “These are not diabetes drugs. These are drugs that have multiple purposes, including obesity and diabetes, and possibly they might even help protect the brain.” – Roger McIntyre, MD

Endocrinology, Diabetes, Metabolism January 21st 2026

Tags: ADDICTION MEDICINE GLP-1s MENTAL HEALTH PEER-TO-PEER SUICIDE

Conexiant

Oral PCSK9 Inhibitor Tied to LDL-C Drop

LDL-C reductions were evident by week 4 and sustained through 52 weeks (−55.3% vs 8.7%).

Cardiology January 6th 2026

Tags: HYPERCHOLESTEROLEMIA LIPID HEALTH PCSK9 INHIBITORS

Medical News Today (MNT)

To Keep Your Heart Healthy, Try Drinking More Orange Juice

“What’s unique about our study is that we used the transcriptomic approach to evaluate the effects of orange juice on the entire metabolic system, allowing us to see how multiple pathways are modulated simultaneously.”

Cardiology January 6th 2026

Tags: DIET & NUTRITION GENE EXPRESSION HEART HEALTH PATIENT EDUCATION PREVENTIVE MEDICINE

Annals of Internal Medicine

Effect of Interventions Aimed at Reducing or Modifying Saturated Fat Intake on Cholesterol, Mortality, and Major Cardiovascular Events

“For persons at low cardiovascular risk, reducing or modifying saturated fat intake has little or no benefit over a period of 5 years.”

Cardiology January 6th 2026

Tags: CARDIOVASCULAR EVENTS DIET & NUTRITION GUIDELINES/RECOMMENDATIONS LIPID HEALTH PREVENTIVE MEDICINE

Medical News Today (MNT)

D3 Supplements Could Halve the Risk of a Second Heart Attack

“The targeted vitamin D3 treatment group had half as many follow-up heart attacks as the control group—3.8% versus 7.9%.”

Cardiology December 3rd 2025

Tags: HEART ATTACK/MYOCARDIAL INFARCTION PREVENTIVE MEDICINE SECONDARY PREVENTION VITAMINS/SUPPLEMENTS

MedCentral

Semaglutide Fails to Meet Desired Endpoints for Alzheimer’s

“Biomarkers have moved in a healthy direction through the intervention, yet clinical responses did not see a statistically significant benefit during the duration of the trial.” — Alzheimer’s Association

Endocrinology, Diabetes, Metabolism December 2nd 2025

Tags: ALZHEIMER'S/DEMENTIA GLP-1s RESEARCH & CLINICAL TRIALS

1 2 … 79 80 >>

Trending Topics:

Articles related to Endocrinology, Diabetes, Metabolism

View More Articles On:

Is Anti-Suicidality Next on the GLP-1 Dropdown Menu?

Oral PCSK9 Inhibitor Tied to LDL-C Drop

To Keep Your Heart Healthy, Try Drinking More Orange Juice

Effect of Interventions Aimed at Reducing or Modifying Saturated Fat Intake on Cholesterol, Mortality, and Major Cardiovascular Events

D3 Supplements Could Halve the Risk of a Second Heart Attack

Semaglutide Fails to Meet Desired Endpoints for Alzheimer’s

Topics

Sources

The Healthcare Communications Network is owned and operated by IQVIA Inc. Click below to leave this site and continue to IQVIA’s Privacy Choices form

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form